A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Rhythm Management Group Launches RhythmSynergy™ Technology Platform

Rhythm Management Group, PLLC, has completed the launch of RhythmSynergy™, a powerful new technology platform that leverages machine-learning to efficiently deliver timely and relevant clinical insights for remotely monitored patients with implantable cardiac devices and wearable devices such as blood pressure cuffs, scales, and glucometers.

Recognized as one of the fastest growing companies in North America, Rhythm has more than a decade of experience centralizing and streamlining remote monitoring operational workflows for medical practices and health systems. It applied that knowledge to RhythmSynergy, focusing on features that enhance efficiency such as automated image processing and intuitive reporting.

“With over 10 years in the remote monitoring space and more than 100 years of combined clinical experience, we understand what staff and clinicians need from their remotely monitored data,” said Rhonda Bray, RN, Founder and CEO, Rhythm Management Group. “By extracting that information and providing clinically validated alerts, we accelerate risk identification so users of RhythmSynergy can provide more timely care.”

Key features of RhythmSynergy include:

  • Intuitive clinical and operational reporting
  • Automated image processing
  • Bi-directional EHR integration
  • Mobile and desktop optimized
  • Compliance with industry-leading security standards
  • Secure and scalable infrastructure

By combining clinical expertise and machine-learning technology, RhythmSynergy prioritizes critical information and streamlines review processes. Its sleek, secure design and powerful reporting tools make it easy to review, share, and analyze patient data. By employing automated data processing and real-time alerts, RhythmSynergy enables faster identification of patient health problems so physicians can intervene sooner.

Dr. John P. McKenzie, of Heartbeat Cardiovascular Medical Group, of Glendale, CA, a Rhythm customer, said, “Rhythm’s remote monitoring program, experienced clinical and engagement teams, and RhythmSynergy platform help us deliver better outcomes for patients without burdening our staff. The platform provides the data we need to make critical, informed care decisions, and optimizes data management by helping us achieve 90 percent remote monitoring penetration.”

The RhythmSynergy platform is available for both types of remote monitoring provided by Rhythm Management Group: Cardiac Rhythm Management (CRM) Monitoring, which is for patients with implantable cardiac devices, and Remote Physiologic Monitoring (RPM), which is for patients with smart health tech wireless devices like blood pressure cuffs, scales, and glucometers.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy